UCB Dividends and Buybacks
Dividend criteria checks 0/6
UCB is a dividend paying company with a current yield of 0.75%.
Key information
0.8%
Dividend yield
0.5%
Buyback Yield
| Total Shareholder Yield | 1.2% |
| Future Dividend Yield | 0.8% |
| Dividend Growth | 2.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €1.360 |
| Payout ratio | 108% |
Recent dividend and buyback updates
Recent updates
Is UCB (EBR:UCB) A Risky Investment?
Dec 24
Why We're Not Concerned About UCB SA's (EBR:UCB) Share Price
Oct 22These 4 Measures Indicate That UCB (EBR:UCB) Is Using Debt Reasonably Well
Sep 10Analysts Have Made A Financial Statement On UCB SA's (EBR:UCB) Half-Yearly Report
Jul 28Investors Still Waiting For A Pull Back In UCB SA (EBR:UCB)
Jul 15Shareholders Will Probably Not Have Any Issues With UCB SA's (EBR:UCB) CEO Compensation
Apr 19Is UCB (EBR:UCB) A Risky Investment?
Mar 27Earnings Tell The Story For UCB SA (EBR:UCB) As Its Stock Soars 26%
Mar 04Stability and Growth of Payments
Fetching dividends data
Stable Dividend: UCB is not paying a notable dividend for the Belgian market, therefore no need to check if payments are stable.
Growing Dividend: UCB is not paying a notable dividend for the Belgian market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| UCB Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (UCB) | 0.8% |
| Market Bottom 25% (BE) | 2.3% |
| Market Top 25% (BE) | 7.4% |
| Industry Average (Pharmaceuticals) | 2.7% |
| Analyst forecast (UCB) (up to 3 years) | 0.8% |
Notable Dividend: UCB's dividend (0.75%) isn’t notable compared to the bottom 25% of dividend payers in the Belgian market (2.29%).
High Dividend: UCB's dividend (0.75%) is low compared to the top 25% of dividend payers in the Belgian market (7.7%).
Earnings Payout to Shareholders
Earnings Coverage: UCB is not paying a notable dividend for the Belgian market.
Cash Payout to Shareholders
Cash Flow Coverage: UCB is not paying a notable dividend for the Belgian market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/15 12:10 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
UCB SA is covered by 49 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mark van der Geest | ABN AMRO Bank N.V. |
| Kamla Singh | AlphaValue |
| Brian Bourdot | Barclays |